These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Acute intermittent porphyria. Day RS; Eales L S Afr Med J; 1982 Feb; 61(8):260-1. PubMed ID: 7058452 [No Abstract] [Full Text] [Related]
5. PORPHOBILINOGEN AND DELTA-AMINOLEVULINIC ACID EXCRETION IN MULTIPLE SCLEROSIS. TAYLOR JD; PAZDER LH; MARKLE V Can Med Assoc J; 1965 Jun; 92(26):1342-4. PubMed ID: 14312444 [TBL] [Abstract][Full Text] [Related]
6. Quantitation of 3-ethyl-5-hydroxy-4,5-dimethyl-delta 3-pyrrolin-2-one in the urine of patients with acute intermittent porphyria. Graham DJ; Brodie MJ; McColl KE; Moore MR; Goldberg A Eur J Clin Invest; 1979 Feb; 9(1):49-53. PubMed ID: 110600 [No Abstract] [Full Text] [Related]
7. [Porphyrins and their precursors in the urine of patients with suspected porphyria; a 16-year experience]. Zawirska B; Kwiatkowska W; Nowojska A Pol Tyg Lek; 1985 Jan; 40(4):97-100. PubMed ID: 3983004 [No Abstract] [Full Text] [Related]
8. [On the problem of treatment of acute intermittent porphyria with ovulation inhibitors. (Studies of delta-aminolevulinic acid, porphobilinogen and total porphyrin excretion)]. Hocevar V; Rausch-Stroomann JG Klin Wochenschr; 1968 Oct; 46(20):1114-6. PubMed ID: 5706556 [No Abstract] [Full Text] [Related]
9. [On the excretion of 5-aminolevulinic acid and porphobilinogen in latent porphyria]. KELENYI G; ARATO G; BUDA V; ORBAN S Folia Haematol Int Mag Klin Morphol Blutforsch; 1961; 78():205-13. PubMed ID: 14454906 [No Abstract] [Full Text] [Related]
10. Comparative effects of glycerol and dextrose on porphyrin precursor excretion in acute intermittent porphyria. Bonkowsky HL; Magnussen CR; Collins AR; Doherty JM; Hess RA; Tschudy DP Metabolism; 1976 Apr; 25(4):405-14. PubMed ID: 1263834 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of a new specific analysis of urinary delta-aminolevulinic acid in man. Witting U; Binding N; Müller G Int Arch Occup Environ Health; 1987; 59(4):375-83. PubMed ID: 3610337 [TBL] [Abstract][Full Text] [Related]
12. Optimized liquid-chromatographic method for fluorometric determination of urinary delta-aminolevulinic acid in workers exposed to lead. Tomokuni K; Ichiba M; Hirai Y; Hasegawa T Clin Chem; 1987 Sep; 33(9):1665-7. PubMed ID: 3621570 [TBL] [Abstract][Full Text] [Related]
14. Comparison of urinary delta-aminolevulinic acid excretion and erythrocyte delta-aminolevulinic acid dehydratase inhibition in different strains of mice exposed to lead. Tomokuni K; Ichiba M; Hirai Y Ind Health; 1990; 28(1):31-6. PubMed ID: 2323962 [No Abstract] [Full Text] [Related]
15. High performance liquid chromatographic procedure for quantitative determination of urinary delta-aminolevulinic acid as indices of lead exposure. Ogata M; Taguchi T Int Arch Occup Environ Health; 1987; 59(4):385-91. PubMed ID: 3610338 [TBL] [Abstract][Full Text] [Related]
16. [Normal levels of delta-aminolevulinic acid in the spot urines of adult men, as measured by a simplified method (author's transl)]. Tomokuni K; Ogata M Sangyo Igaku; 1980 Mar; 22(2):92-5. PubMed ID: 7401387 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis of a case of acute intermittent porphyria with the aid of thin-layer chromatography-thin-layer electrophoresis of urine. Samuels S; Veliz G Clin Chem; 1971 Jan; 17(1):51-2. PubMed ID: 5538582 [No Abstract] [Full Text] [Related]
18. Porphobilinogen-synthase (delta-aminolevulinic acid dehydratase) deficiency in bone marrow cells of two patients with porphobilinogen-synthase defect acute porphyria. Doss M; Tiepermann RV; Schneider J Klin Wochenschr; 1983 Jul; 61(14):699-702. PubMed ID: 6887758 [TBL] [Abstract][Full Text] [Related]
19. [Improved method for the determination of urinary delta-aminolevulinic acid in lead workers]. Tomokuni K; Hasegawa N; Sugawara E Sangyo Igaku; 1986 Mar; 28(2):114-8. PubMed ID: 3761711 [TBL] [Abstract][Full Text] [Related]